相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antihyperglycemic effect of fraxetin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats
Raju Murali et al.
BIOCHIMIE (2013)
Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity
Nattha Jariyapamornkoon et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Poly(DL-lactide-co-glycolic acid) Nanoparticle Design and Payload Prediction: A Molecular Descriptor Based Study
Suvadra Das et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2013)
Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine
Indu Barwal et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
A novel insulin mimetic vanadium-flavonol complex: Synthesis, characterization and in vivo evaluation in STZ-induced rats
Subramanian Iyyam Pillai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana
Naveen Shivanna et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
Engineered Andrographolide Nanoparticles Mitigate Paracetamol Hepatotoxicity in Mice
Partha Roy et al.
PHARMACEUTICAL RESEARCH (2013)
In vivo recovery effect of silibinin treatment on streptozotocin-induced diabetic mice is associated with the modulations of sirt-1 expression and autophagy in pancreatic β-cell
Qiong Wang et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2012)
Silyrnarin regulates the cytochrome P450 3A2 and glutathione peroxides in the liver of streptozotocin-induced diabetic rats
H. Malekinejad et al.
PHYTOMEDICINE (2012)
Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil
Shifeng Yan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Chitosan Reduces Gluconeogenesis and Increases Glucose Uptake in Skeletal Muscle in Streptozotocin-Induced Diabetic Rats
Shing-Hwa Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells
Murali Mohan Yallapu et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2010)
Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases
Lanjuan Li et al.
NANO TODAY (2010)
Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus
C. Soto et al.
PHYTOMEDICINE (2010)
Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles
Avinash Budhian et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Raghavendra C. Mundargi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Elaine M. Merisko-Liversidge et al.
TOXICOLOGIC PATHOLOGY (2008)
Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus
A. I. Vengerovskii et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats
Kannampalli Pradeep et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites
Carmen S. L. Hoh et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
The flavonoid Silibinin decreases glucose-6-phosphate hydrolysis in perifused rat Hepatocytes by an inhibitory effect on glucose-6-phosphatase
Bruno Guigas et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Silymarin and its components scavenge phenylglyoxylic ketyl radicals
Frantisek Sersen et al.
FITOTERAPIA (2006)
The efficacy of Silybum marianum (L.) Gaertn. (Silymarin) in the treatment of type II diabetes:: A randomized, double-blind, placebo-controlled, clinical trial
H. Fallah Huseini et al.
PHYTOTHERAPY RESEARCH (2006)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Study of the hypoglycaemic activity of Fraxinus excelsior and Silybum marianum in an animal model of type 1 diabetes mellitus
M Maghrani et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
Silymarin induces recovery of pancreatic function after alloxan damage in rats
C Soto et al.
LIFE SCIENCES (2004)
Hyperglycemia-induced oxidative stress in diabetic complications
GL King et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Analysis of the active components of silymarin
F Kvasnicka et al.
JOURNAL OF CHROMATOGRAPHY A (2003)
Engineering protein and cell adhesivity using PEO-terminated triblock polymers
VA Liu et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH (2002)
Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control
EY Sözmen et al.
ARCHIVES OF MEDICAL RESEARCH (2001)
Oxidative stress impairs insulin internalization in endothelial cells in vitro
M Bertelsen et al.
DIABETOLOGIA (2001)
The use of silymarin in the treatment of liver diseases
R Saller et al.
DRUGS (2001)
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
T Inoguchi et al.
DIABETES (2000)
分享论文
